Back to FAQ Categories
Immunotherapy FAQs
Related Questions
Immunotherapy
How Long Does Immunotherapy Stay in Your System?
How long immunotherapy stays in the body depends on the type of treatment. Immunotherapy drugs generally stay in your system for 3-16 weeks after the last dose, with some immune-modulating effects lasting much longer.
Common checkpoint inhibitors like Keytruda and Opdivo have half-lives of approximately 22-25 days.
Drug Half-Life vs. Biological Effect
When asking how long immunotherapy stays in your system, it helps to separate two distinct concepts:
- Physical drug clearance — how long the drug molecule is detectable in your blood (measured by half-life)
- Biological effect — how long the changes to your immune system persist, which can outlast the drug itself by many months or years
Unlike chemotherapy, which targets cancer cells directly, immunotherapy reprograms the immune system. Those reprogrammed immune cells can remain active long after the drug has been metabolized, which is one reason some patients see long-term or lasting remissions.
How Long Do Specific Immunotherapy Types Remain in the Body?
| Type | Example | Half Life | Dosing Schedule |
|---|---|---|---|
| Checkpoint Inhibitors (most common) | Nivolumab (Opdivo®) or Pembrolizumab (Keytruda®) | 22-25 20-27 days | Every 2–6 weeks |
| Cytokine-Based Therapies | Interleukin-2 | Hours | Every ~8 hours |
| CAR T-Cell Therapy | Tisagenlecleucel (Kymriah®) or Axicabtagene ciloleucel (Yescarta®) | Not cleared like a drug — they can multiply and persist in the body | May remain active for months to years |
Can Side Effects Occur After Immunotherapy Ends?
Because immunotherapy activates the immune system, immune-related adverse events (irAEs) can occur even after treatment has stopped. These may include:
- Persistent fatigue
- Joint pain or muscle aches
- Thyroid dysfunction, adrenal insufficiency, or other hormone-related issues that may require ongoing management
- Inflammatory conditions affecting the skin, lungs, liver, or bowel
Note that patients should continue follow-up care with their oncologist and report any new symptoms — even months after finishing treatment.
What Factors Affect How Long Immunotherapy Stays in Your System?
Note that the clearance timeline varies from patient to patient based on:
- Body weight — dosing is often weight-based, which affects concentration and clearance
- Kidney and liver function — organ health influences how quickly large protein-based drugs are broken down
- Specific drug and formulation — each immunotherapy agent has a unique pharmacokinetic profile
- Tumor burden and immune environment — can affect how strongly the immune system is activated and for how long
Is Immunotherapy Right For You?
If your doctor has recommended immunotherapy or you'd like to learn whether immunotherapy may be an option for you, contact AmeriPharma Specialty Care to speak with a specialist today.
24/7/365 Phone support
Open on all federal holidays